• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法尼醇 X 受体和胆汁酸对人胆汁酸 UDP-葡糖醛酸基转移酶 1A3 的调控。

Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.

机构信息

Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg Str. 1, Hannover, Germany.

出版信息

J Hepatol. 2010 Apr;52(4):570-8. doi: 10.1016/j.jhep.2010.01.010. Epub 2010 Feb 4.

DOI:10.1016/j.jhep.2010.01.010
PMID:20189675
Abstract

BACKGROUND & AIMS: Cholestasis is a serious complication of many liver diseases leading to increased serum bile acids (BA) and their conjugates. Chenodeoxycholic (CDCA) acid is a substrate of the human hepatic UDP-glucuronosyltransferase (UGT) 1A3. UGT1A3 may, therefore, be a BA-inducible gene relevant to BA regulation.

METHODS

BA and human bile were used to induce UGT1A3 in HepG2 cells. Genomic DNA was analyzed by PCR amplification and sequencing. Transcriptional regulation was studied by DNA mutagenesis, RT-PCR, luciferase reporter gene constructs and electrophoretic mobility shift assays (EMSA).

RESULTS

CDCA differentially induced UGT1A3 but not UGT1A4 expression. Bile from ursodeoxycholic acid (UDCA)-treated and untreated patients differentially induced UGT1A3. A farnesoid X receptor (FXR) half-site DNA motif was identified in the UGT1A3 5' upstream region. The FXR inducer GW4064 activated UGT1A3 transcription, and electrophoretic mobility shift assays identified UGT1A3 as a FXR target gene.

CONCLUSIONS

Transcriptional regulation of the human bile acid and xenobiotic UGT1A3 by its substrate CDCA and FXR is shown. CDCA glucuronidation can be controlled by feed back inhibition proceeding via the glucuronidation of CDCA. UDCA does not induce UGT1A3 transcription. Since UGT1A3 is significantly induced by xenobiotics this physiologically links xenobiotic and bile acid metabolism to cholestasis.

摘要

背景与目的

胆淤积是许多肝脏疾病的严重并发症,导致血清胆汁酸(BA)及其共轭物增加。鹅去氧胆酸(CDCA)是人类肝 UDP-葡糖醛酸基转移酶(UGT)1A3 的底物。因此,UGT1A3 可能是与 BA 调节相关的 BA 诱导基因。

方法

用 BA 和人胆汁诱导 HepG2 细胞中的 UGT1A3。通过 PCR 扩增和测序分析基因组 DNA。通过 DNA 诱变、RT-PCR、荧光素酶报告基因构建体和电泳迁移率变动分析(EMSA)研究转录调控。

结果

CDCA 差异诱导 UGT1A3 但不诱导 UGT1A4 表达。来自熊去氧胆酸(UDCA)治疗和未治疗患者的胆汁差异诱导 UGT1A3。在 UGT1A3 5'上游区域鉴定出法尼醇 X 受体(FXR)半位点 DNA 基序。FXR 诱导剂 GW4064 激活 UGT1A3 转录,电泳迁移率变动分析鉴定 UGT1A3 为 FXR 靶基因。

结论

显示了人胆汁酸和外源性 UGT1A3 的转录调节,由其底物 CDCA 和 FXR 进行。CDCA 的葡萄糖醛酸化可以通过 CDCA 的葡萄糖醛酸化进行反馈抑制来控制。UDCA 不诱导 UGT1A3 转录。由于 UGT1A3 被外源性物质显著诱导,因此这在生理上将外源性物质和胆汁酸代谢与胆淤积联系起来。

相似文献

1
Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.法尼醇 X 受体和胆汁酸对人胆汁酸 UDP-葡糖醛酸基转移酶 1A3 的调控。
J Hepatol. 2010 Apr;52(4):570-8. doi: 10.1016/j.jhep.2010.01.010. Epub 2010 Feb 4.
2
Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver.人尿苷二磷酸葡萄糖醛酸基转移酶(UGT)1A3在肝脏中催化鹅去氧胆酸的结合反应。
Hepatology. 2006 Nov;44(5):1158-70. doi: 10.1002/hep.21362.
3
Aryl hydrocarbon receptor-mediated regulation of the human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene.芳烃受体介导的人类雌激素和胆汁酸UDP-葡萄糖醛酸基转移酶1A3基因的调控
Arch Toxicol. 2008 Sep;82(9):573-82. doi: 10.1007/s00204-008-0347-1. Epub 2008 Aug 2.
4
Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.胆汁酸通过法尼酯X受体的激活诱导人过氧化物酶体增殖物激活受体α基因的表达。
Mol Endocrinol. 2003 Feb;17(2):259-72. doi: 10.1210/me.2002-0120.
5
Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.鹅去氧胆酸通过激活法尼醇 X 受体诱导细胞解毒酶表达是通过 AMP 激活的蛋白激酶和细胞外信号调节激酶 1/2 磷酸化 CCAAT/增强子结合蛋白 β 实现的。
Drug Metab Dispos. 2011 Aug;39(8):1451-9. doi: 10.1124/dmd.111.038414. Epub 2011 May 19.
6
The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic mice.肝脏X受体α在人类细胞和转基因小鼠中控制人胆汁酸葡萄糖醛酸化UGT1A3酶的肝脏表达。
Hepatology. 2006 Aug;44(2):368-78. doi: 10.1002/hep.21259.
7
Bile acid-induced negative feedback regulation of the human ileal bile acid transporter.胆汁酸对人回肠胆汁酸转运体的负反馈调节
Hepatology. 2004 Jul;40(1):149-56. doi: 10.1002/hep.20295.
8
Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.熊去氧胆酸对Caco-2细胞中回肠胆汁酸结合蛋白表达的调节:法尼酯X受体的作用
Biochem Pharmacol. 2005 Jun 15;69(12):1755-63. doi: 10.1016/j.bcp.2005.03.019.
9
Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.人法尼醇 X 受体的差异激活取决于表达的同工型模式和胆汁酸池组成。
Biochem Pharmacol. 2013 Oct 1;86(7):926-39. doi: 10.1016/j.bcp.2013.07.022. Epub 2013 Aug 6.
10
The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion.法尼酯X受体以配体和启动子选择性的方式控制基因表达。
J Biol Chem. 2004 Mar 5;279(10):8856-61. doi: 10.1074/jbc.M306422200. Epub 2003 Dec 18.

引用本文的文献

1
Double-negative T cells in combination with ursodeoxycholic acid ameliorates immune-mediated cholangitis in mice.双阴性T细胞与熊去氧胆酸联合使用可改善小鼠免疫介导的胆管炎。
BMC Med. 2025 Apr 7;23(1):209. doi: 10.1186/s12916-025-04043-9.
2
A Mechanistic Study of the Feasibility of Ursodeoxycholic Acid in the Treatment of Colon Adenocarcinoma.熊去氧胆酸治疗结肠腺癌可行性的机制研究
Drug Des Devel Ther. 2025 Mar 12;19:1839-1852. doi: 10.2147/DDDT.S500721. eCollection 2025.
3
Microbiota governs host chenodeoxycholic acid glucuronidation to ameliorate bile acid disorder induced diarrhea.
微生物群调控宿主鹅去氧胆酸葡萄糖醛酸化,以改善胆汁酸紊乱引起的腹泻。
Microbiome. 2025 Feb 4;13(1):36. doi: 10.1186/s40168-024-02011-8.
4
UDP-glucuronosyltransferases mediate coffee-associated reduction of liver fibrosis in bile duct ligated humanized transgenic mice.UDP-葡糖醛酸基转移酶介导胆管结扎的人源化转基因小鼠中咖啡相关的肝纤维化减轻。
Hepatobiliary Surg Nutr. 2021 Dec;10(6):766-781. doi: 10.21037/hbsn-20-9.
5
Tetrahydrofurofuranoid Lignans, Eudesmin, Fargesin, Epimagnolin A, Magnolin, and Yangambin Inhibit UDP-Glucuronosyltransferase 1A1 and 1A3 Activities in Human Liver Microsomes.四氢呋喃型木脂素、去甲二氢愈创木酸、法尔吉新、表木兰脂素A、木兰脂素和洋姜黄酮抑制人肝微粒体中尿苷二磷酸葡萄糖醛酸基转移酶1A1和1A3的活性。
Pharmaceutics. 2021 Feb 1;13(2):187. doi: 10.3390/pharmaceutics13020187.
6
The coffee ingredients caffeic acid and caffeic acid phenylethyl ester protect against irinotecan-induced leukopenia and oxidative stress response.咖啡成分咖啡酸和咖啡酸苯乙酯可预防伊立替康引起的白细胞减少症和氧化应激反应。
Br J Pharmacol. 2020 Sep;177(18):4193-4208. doi: 10.1111/bph.15162. Epub 2020 Jul 16.
7
A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic mice.一个与吉尔伯特综合征相关的单倍型可保护人源化转基因小鼠免于发生脂肪肝疾病。
Sci Rep. 2020 May 26;10(1):8689. doi: 10.1038/s41598-020-65481-4.
8
In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.合成大麻素EAM - 2201对人肝微粒体中细胞色素P450和尿苷二磷酸葡萄糖醛酸转移酶活性的体外抑制作用
Molecules. 2018 Apr 16;23(4):920. doi: 10.3390/molecules23040920.
9
Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics.全面的药物基因组学研究揭示 UGT1A3 在孟鲁司特药代动力学中的重要作用。
Clin Pharmacol Ther. 2018 Jul;104(1):158-168. doi: 10.1002/cpt.891. Epub 2017 Nov 6.
10
AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.AM-2201抑制人肝微粒体中的多种细胞色素P450和尿苷5'-二磷酸葡萄糖醛酸基转移酶活性。
Molecules. 2017 Mar 10;22(3):443. doi: 10.3390/molecules22030443.